Search | CATIE - Canada's source for HIV and hepatitis C information

Jump to Navigation Jump to Content

Sort Results

Filter by Topic

Organ and body health (remove)
- Fat redistribution (remove)
- Weight loss and wasting syndrome (1)
Treatment (2)

Filter by Infection

HIV (remove)

Filter by Resource Category

Search results

Current filters: HIV, English, Organ and body health, Fat redistribution

8 search results

Tesamorelin (Egrifta) comes to Canada—what you need to know: 2015, CATIE
Research summary - Webpage
Unusual and rare complication described in San Francisco: 2013, CATIE
Research summary - Webpage
3. Body Weight and Body Shape Changes: From A Practical Guide to HIV Drug Side Effects
2013, CATIE
Client resources - Webpage
Face fillers and dental work—caution needed: 2012, CATIE
Research summary - Webpage
Changes in body fat and muscle with lopinavir-ritonavir: From TreatmentUpdate 182
2011, CATIE
Research summary - Webpage
Tesamorelin—overview: From TreatmentUpdate 182
2011, CATIE
Research summary - Webpage
Tesamorelin helps reduce belly fat: From TreatmentUpdate 182
2011, CATIE
Research summary - Webpage
Complications reported in some recipients of Bio Alcamid: 2010, CATIE
Research summary - Webpage

Production of this Web site has been made possible through a financial contribution from the Public Health Agency of Canada.

We comply with the HONcode standard for trustworthy health information: verify here.

Please note that some content on this website contains language, information and images related to sexuality and drug use, and may not be intended for people of all ages. CATIE ensures that these resources, developed to help prevent the transmission of HIV, hepatitis C and other infections, are written and reviewed by health experts for content accuracy.